当前位置:首页 - 行情中心 - 凯赛生物(688065) - 财务分析

凯赛生物

(688065)

  

流通市值:313.45亿  总市值:387.55亿
流通股本:5.83亿   总股本:7.21亿

凯赛生物(688065)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润2.84亿元,每股收益0.47元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益2107478.92万元,未分配利润232764.60万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产2382118.27万元,负债274639.34万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入1,670,767,942.21775,769,935.752,957,911,554.762,215,083,356.3
营业总成本1,283,596,878.98619,368,581.392,361,273,032.481,806,773,748.37
其他经营收益
营业利润345,764,406.94161,685,700.77551,561,171.61389,098,019.4
利润总额342,112,439.58158,040,889.01548,015,229.03387,371,747.02
净利润284,191,771.38124,318,691.92474,589,331.67338,433,720.91
每股收益
其他综合收益4,035,669.853,862,477.8-5,486,780.85216,838.63
综合收益总额288,227,441.23128,181,169.72469,102,550.82338,650,559.54
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计12,011,651,589.2812,947,798,435.287,386,914,396.786,812,364,351.97
非流动资产:
非流动资产合计11,809,531,078.4711,742,069,967.911,634,562,952.8611,517,671,650.76
资产总计23,821,182,667.7524,689,868,403.1819,021,477,349.6418,330,036,002.73
流动负债:
流动负债合计1,876,141,935.872,538,495,884.892,917,855,546.032,374,106,190.4
非流动负债:
非流动负债合计870,251,506.821,006,056,817.11,002,549,593.88966,745,562.18
负债合计2,746,393,442.693,544,552,701.993,920,405,139.913,340,851,752.58
所有者权益(或股东权益):
归属于母公司股东权益合计17,452,567,422.3817,563,815,224.8111,507,005,495.2511,386,757,208.87
股东权益合计21,074,789,225.0621,145,315,701.1915,101,072,209.7314,989,184,250.15
负债和股东权益合计23,821,182,667.7524,689,868,403.1819,021,477,349.6418,330,036,002.73
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计1,812,430,577.73744,764,366.483,351,448,965.932,455,832,300.56
经营活动现金流出小计1,473,116,722.4657,274,979.572,530,519,633.511,779,816,342.83
经营活动产生的现金流量净额339,313,855.3287,489,386.91820,929,332.42676,015,957.73
投资活动产生的现金流量:
投资活动现金流入小计410,102,862.31-20,252,268.7430,046,199
投资活动现金流出小计1,883,735,109.6305,227,020.78843,313,170.45643,949,366.3
投资活动产生的现金流量净额-1,473,632,247.29-305,227,020.78-823,060,901.71-613,903,167.3
筹资活动产生的现金流量:
筹资活动现金流入小计6,458,513,203.026,293,622,576.951,889,290,806.481,295,208,915.3
筹资活动现金流出小计1,822,280,245.26628,364,962.171,739,798,822.611,708,887,914.21
筹资活动产生的现金流量净额4,636,232,957.765,665,257,614.78149,491,983.87-413,678,998.91
汇率变动对现金及现金等价物的影响-4,105,233.672,366,523.9924,824,735.62-28,144,057.36
现金及现金等价物净增加额3,497,809,332.125,449,886,504.9172,185,150.2-379,710,265.84
期末现金及现金等价物余额8,683,774,045.2410,635,851,218.025,185,964,713.124,634,069,297.08
补充资料:
现金及现金等价物的净增加额3,497,809,332.12-172,185,150.2-
最新报告期:2025-08-25
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华安证券刘天其,王强峰0.951.181.562025-08-25
华创证券杨晖,郑轶0.951.261.492025-08-21
中信证券李超,王喆0.911.111.252025-08-21
申万宏源周超,宋涛,马昕晔0.901.131.402025-08-19
TOP↑